Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS

Shahideh Amini, Aysa Rezabakhsh, Javad Hashemi, Fatemeh Saghafi, Hossein Azizi, Antoni Sureda, Solomon Habtemariam, Hamid Reza Khayat Kashani, Zahra Hesari, Adeleh Sahebnasagh

Open source

DOI: 10.1186/s40560-022-00625-4
Published: 2022-07-30
Container: Journal of Intensive Care
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40560-022-00625-4,
  title = {Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS},
  author = {Shahideh Amini and Aysa Rezabakhsh and Javad Hashemi and Fatemeh Saghafi and Hossein Azizi and Antoni Sureda and Solomon Habtemariam and Hamid Reza Khayat Kashani and Zahra Hesari and Adeleh Sahebnasagh},
  year = {2022},
  journal = {Journal of Intensive Care},
  doi = {10.1186/s40560-022-00625-4},
  url = {https://doi.org/10.1186/s40560-022-00625-4}
}

RIS

TY  - JOUR
TI  - Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS
AU  - Shahideh Amini
AU  - Aysa Rezabakhsh
AU  - Javad Hashemi
AU  - Fatemeh Saghafi
AU  - Hossein Azizi
AU  - Antoni Sureda
AU  - Solomon Habtemariam
AU  - Hamid Reza Khayat Kashani
AU  - Zahra Hesari
AU  - Adeleh Sahebnasagh
PY  - 2022
JO  - Journal of Intensive Care
DO  - 10.1186/s40560-022-00625-4
UR  - https://doi.org/10.1186/s40560-022-00625-4
ER  -

APA

Amini, S., Rezabakhsh, A., Hashemi, J., Saghafi, F., Azizi, H., Sureda, A., Habtemariam, S., Kashani, H. R. K., Hesari, Z., & Sahebnasagh, A. (2022). Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS. Journal of Intensive Care. https://doi.org/10.1186/s40560-022-00625-4

Source records

crossref · retrieved 2026-09-26T13:35:54.769Z